Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fallarino

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Current Medicinal Chemistry|April 27, 2011
Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functionsF Fallarino, U Grohmann
Therapeutic Immunology|August 1, 1995
Rational development of tumour antigen-specific immunization in melanomaT F Gajewski, F Fallarino
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1F Fallarino, T F Gajewski
Current Pharmaceutical Design|February 4, 2006
Mechanisms of CTLA-4-Ig in tolerance inductionM-L Alegre, F Fallarino
Cell Cycle (Georgetown, Tex.)|December 9, 2014
AhR: far more than an environmental sensorF Fallarino, L Romani, P Puccetti
Neuropharmacology|May 30, 2012
Targeting metabotropic glutamate receptors in neuroimmune communicationC Volpi, F Fazio, F Fallarino
The Journal of Experimental Medicine|July 7, 1998
B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28F Fallarino, P E Fields, T F Gajewski
European Cytokine Network|July 10, 1999
Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPLS Silla, F Fallarino, T Boon, et al.
International Immunology|October 6, 1997
Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cellsF Fallarino, A Ashikari, T Boon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1996
Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivoF Fallarino, C Uyttenhove, T Boon, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current Medicinal Chemistry|April 27, 2011
Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functionsF Fallarino, U Grohmann
Therapeutic Immunology|August 1, 1995
Rational development of tumour antigen-specific immunization in melanomaT F Gajewski, F Fallarino
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1F Fallarino, T F Gajewski
Current Pharmaceutical Design|February 4, 2006
Mechanisms of CTLA-4-Ig in tolerance inductionM-L Alegre, F Fallarino
Cell Cycle (Georgetown, Tex.)|December 9, 2014
AhR: far more than an environmental sensorF Fallarino, L Romani, P Puccetti
Neuropharmacology|May 30, 2012
Targeting metabotropic glutamate receptors in neuroimmune communicationC Volpi, F Fazio, F Fallarino
The Journal of Experimental Medicine|July 7, 1998
B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28F Fallarino, P E Fields, T F Gajewski
European Cytokine Network|July 10, 1999
Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPLS Silla, F Fallarino, T Boon, et al.
International Immunology|October 6, 1997
Antigen-specific regression of established tumors induced by active immunization with irradiated IL-12- but not B7-1-transfected tumor cellsF Fallarino, A Ashikari, T Boon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1996
Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivoF Fallarino, C Uyttenhove, T Boon, et al.
Pageof 4